CD8A and cancer: Indeed, many studies, including adoptive transfer and antibody depletion experiments, have clearly shown that cytotoxic CD8+ T cells are the key effector cells responsible for immune control of cancer (Dunn et al, 2002; Dunn et al, 2004).